BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 7926300)

  • 1. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.
    Hotamisligil GS; Spiegelman BM
    Diabetes; 1994 Nov; 43(11):1271-8. PubMed ID: 7926300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
    Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
    J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus.
    Katsuki A; Sumida Y; Murashima S; Murata K; Takarada Y; Ito K; Fujii M; Tsuchihashi K; Goto H; Nakatani K; Yano Y
    J Clin Endocrinol Metab; 1998 Mar; 83(3):859-62. PubMed ID: 9506740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
    Hamann A; Benecke H; Le Marchand-Brustel Y; Susulic VS; Lowell BB; Flier JS
    Diabetes; 1995 Nov; 44(11):1266-73. PubMed ID: 7589822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and insulin resistance in Swedish subjects.
    Arner P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S85-6. PubMed ID: 8894488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.
    Moller DE
    Trends Endocrinol Metab; 2000 Aug; 11(6):212-7. PubMed ID: 10878750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.
    Mishima Y; Kuyama A; Tada A; Takahashi K; Ishioka T; Kibata M
    Diabetes Res Clin Pract; 2001 May; 52(2):119-23. PubMed ID: 11311966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of type 2 diabetes.
    Scheen AJ
    Acta Clin Belg; 2003; 58(6):335-41. PubMed ID: 15068125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance associated to obesity: the link TNF-alpha.
    Nieto-Vazquez I; Fernández-Veledo S; Krämer DK; Vila-Bedmar R; Garcia-Guerra L; Lorenzo M
    Arch Physiol Biochem; 2008 Jul; 114(3):183-94. PubMed ID: 18629684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance.
    Liang H; Yin B; Zhang H; Zhang S; Zeng Q; Wang J; Jiang X; Yuan L; Wang CY; Li Z
    Endocrinology; 2008 Jun; 149(6):2943-51. PubMed ID: 18339717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review).
    Holden RJ; Pakula IS; Mooney PA
    Med Hypotheses; 1999 Apr; 52(4):319-23. PubMed ID: 10465670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.
    Cheung AT; Ree D; Kolls JK; Fuselier J; Coy DH; Bryer-Ash M
    Endocrinology; 1998 Dec; 139(12):4928-35. PubMed ID: 9832430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From obesity to diabetes].
    Stöckli R; Keller U
    Ther Umsch; 2002 Aug; 59(8):388-92. PubMed ID: 12235730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship.
    Nishimura F; Iwamoto Y; Mineshiba J; Shimizu A; Soga Y; Murayama Y
    J Periodontol; 2003 Jan; 74(1):97-102. PubMed ID: 12593603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.
    Hofmann C; Lorenz K; Braithwaite SS; Colca JR; Palazuk BJ; Hotamisligil GS; Spiegelman BM
    Endocrinology; 1994 Jan; 134(1):264-70. PubMed ID: 8275942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
    Boden G
    Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for non-insulin-dependent diabetes mellitus.
    Haffner SM
    J Hypertens Suppl; 1995 Aug; 13(2):S73-6. PubMed ID: 8576792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.
    Uysal KT; Wiesbrock SM; Marino MW; Hotamisligil GS
    Nature; 1997 Oct; 389(6651):610-4. PubMed ID: 9335502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Journey from cachexia to obesity by TNF.
    Argilés JM; López-Soriano J; Busquets S; López-Soriano FJ
    FASEB J; 1997 Aug; 11(10):743-51. PubMed ID: 9271359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.